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Abstract
Background: Research investigating mammography screening has often reported low mammography self-efficacy
and breast cancer fear contribute to underutilization of mammography. This study aimed to examine the reliability
and validity of Champion’s Mammography Self-efficacy Scale (CMSS) and Champion’s Breast Cancer Fear Scale
(CBCFS) in a sample of Iranian women.
Methods: The adapted instruments were administered to a community sample of 482 women aged 40 years or
older. They inhibited in Sanandaj, Iran. Cronbach’s α coefficients, item-total, and test-retest correlations were used to
assess the reliability of the scales. Confirmatory factor analysis was applied to assess construct validity.
Results: The α coefficients for the Farsi 14-item CMSS and 8-item BCFS were .87 and.95, respectively. In terms of the
CMSS confirmatory factor analysis, the proportion of x2/df was 2.4, Comparative Fit Index (CFI) = 0.93, Tucker Lewis
Index (TLI) = 0.96 providing a strong fit to the data induced by two-factor model. With regard to CBCFS, x2/df was 86.
33, CFI =0.99, and TLI =0.99 supporting one-factor model.
Conclusion: The CMSS and CBCFS exhibited strong initial psychometric properties; therefore, they are recommended
to understand women’s breast cancer screening behaviors better.
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Background
It is believed that the higher mortality and lower 5-years
survival rate for breast cancer in Iranian women [1]
might arise from inadequate use of mammography as a
screening method resulting in detection of larger tumors
at later stages. There is no nationwide population-based
breast cancer screening program in Iran. Women who
participate in routine screenings have been found to be
diagnosed with earlier stage disease by 5–13 percentage
points, regardless of race/ethnicity [2]. Improvements in
screening practices have been shown to reduce breast
cancer mortality by approximately 20–35% in women
aged 50–69 and by approximately 20% in women aged
40–49 [3]. In spite of medical recommendations, many
women do not receive regular mammograms in Iran [4, 5].
Increasing mammography use might be the most effective
population wide approach to reduce the morbidity and
mortality associated with breast cancer [6].
Research has found that variables consistently associated
with breast cancer screening behaviors among Iranian
women include perceived susceptibility [7], anticipated
positive outcomes [8], perceived self-efficacy [4], and
barriers [5]. Perceived self-efficacy for mammography has
also been predictive of mammography screening in several
studies [5, 9]. The aforementioned research has empha-
sized the role of self-efficacy in the practice of women
regarding mammography. Perceived self-efficacy is de-
fined as people’s beliefs in their capabilities to achieve
given outcomes [10]. In terms of mammography, self-
efficacy leads to the increased confidence among
women to engage in the steps necessary for obtaining a
mammogram (e.g., finding a mammography service
provider, obtaining a referral, paying for the test, and
preparation for getting a mammogram).
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Self-efficacy may be considered a universal construct,
which means that it characterizes a basic belief that is
inherent in all individuals. Therefore, a cross-cultural
commonality in beliefs about efficacy to produce effects
by personal action might be expected [11]. Accordingly, it
might be assumed that associations between self-efficacy
and related constructs could be similar across cultural
groups. However, without validated measures of self-effi-
cacy (in the present context, breast cancer screening
self-efficacy), assumptions around any cross-cultural
differences or similarities cannot be adequately tested.
There are associations between self-efficacy and other
related constructs that might influence mammography
behaviors. For example, it has been shown that women
with a moderate level of breast cancer fear, in combin-
ation with a higher level of self-efficacy for mammog-
raphy will have greater mammography adherence than
women who experience a high level of breast cancer fear
in combination with lower self-efficacy for mammog-
raphy [12]. Controversial findings have been reported in
studies focusing on fear as a factor influencing breast
screening behavior. Fear about breast cancer has been
shown to reduce participation in breast cancer screening
[13]. This includes worry, fear of having cancer, and fear
of the screening procedure [14]. According to Champion
et al., different operational definitions have been used
for fear of breast cancer, resulting in these conflicting
results [13]. Theoretically, whether or not an individual
engages in a health behavior depends upon his or her
level of fear, self-efficacy, and beliefs in the benefits of
the behavior. Lower levels of self-efficacy are theorized to
be associated with greater breast cancer fear [12, 13, 15].
Women who experience a very high level of breast cancer
fear, especially in combination with lower self-efficacy
[12, 13, 16] and fewer perceived benefits of mammog-
raphy are reported to use mammography less often
[17]. Women experiencing a low level of breast cancer
fear, regardless of self-efficacy and perceived benefits of
mammography may not feel motivated to take action.
The Breast Cancer Fear Scale was developed by Cham-
pion and colleagues to assess the psychological stimulus
and subjective dimensions of the breast cancer fear
construct. The scale comprises items that evaluate
emotional and physiological factors affecting the threat
of breast cancer [13].
To date, instruments that have been utilized to evaluate
a relationship between self-efficacy and mammography
contained statements related to the mammography
procedure [13, 18–20]. However, it is necessary for a
comprehensive instrument assessing self-efficacy for
mammography to cover all the steps involved in the
behavior. One of the instruments that embodies this
characteristic has been developed by Champion and
colleagues [18] .
The concepts of breast cancer fear and self-efficacy are
potentially important predictors of compliance with
mammography. However, assessments of these con-
structs are not available for use among Iranian women
across different cultures. While the psychometric prop-
erties of the mammography self-efficacy scale were pre-
viously evaluated by Hashemian in Sabzevar [20], the
current work was conducted in Sanandaj, a city in the
west of Iran, which is culturally and religiously different
from Sabzevar. It is expected that cultural and religious
factors present in Sanandaj would produce differences in
the mammography self-efficacy items than when the
scale was administered in Sabzevar [20].
This paper aimed to describe the cultural adaptation
and validation of Farsi versions of Champion’s Mam-
mography Self-efficacy Scale (CMSS) and Breast Cancer
Fear Scale (CBCFS) [13]. These measurement tools offer
the potential for more comprehensive understanding of
the relationship between fear and self-efficacy with
mammography adherence by providing clear conceptual
and operational definitions and validated instruments.
Methods
Study design
We used strategies for translation and cultural adapta-
tion of scales recommended by the World Health
Organization [21]. This method involves several steps. In
the first stage, the English version of the (CMSS) and
(CBCFS) were given to two professional translators to
translate into Farsi independently. Then, two bilinguals
converted the translated instrument into the original
language (English) to assure retention of the original
meaning. Then, we made a comparison between the
original and back-translated versions to identify any dif-
ferences. In cases where differences were observed, the
investigators and translators worked together to make
necessary changes in the Farsi translation.
Determination of content validity
Once the items were translated, we convened a panel
consisting of two experts in health education, three gy-
necologists, a midwife, a radiologist, and a psychologist.
The panel members were asked to review the translated
items for each scale and evaluate the items’ relevance to
Iranian culture, appropriateness for Iranian use, and
clarity, together constituting the items’ CVI (Content
Validity Index). Experts were also asked to evaluate each
item on a four-point scale: 4 = very relevant, 3 = relevant
with some adjustment to phrasing, 2 = only relevant if
phrasing is profoundly adjusted and 1 = irrelevant. For
each item, experts could propose improvements in
wording. The CVI was computed as the number of
experts giving a rating of either 3 or 4, divided by the
number of experts—that is, the proportion in agreement
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about relevance. The CVI scale’s score of greater than
0.79 was considered to confirm the content validity of
the scale [21].
Mammography Self-efficacy Scale (MSS)
The instrument we adapted was based on the CMSS
[18]. This is a self-report instrument that includes 10
items which loaded on 1 factor, all scored on a Likert-
type scale ranging from 1 (strongly disagree) to 5
(strongly agree). The expert panel believed that 9 of the
items should remain in the instrument. One item was
recommended for exclusion: "If I really want to get a
mammogram, I can do it” because it’s content in Farsi
was repeated in item 3: “I can arrange other things in
my life to have a mammogram”.
The lack of perceived capability in women to request a
mammogram referral from their physicians was reported
as a barrier in previous studies in Iran [22–24]. There is
no routine recommendation for getting mammogram
[25] and in most cases] women do not get mammog-
raphy unless they request it. In addition, there are no
regular healthcare visits recommended for Iranian
women that assess breast health. For these reasons, the
expert panel suggested assessing women’s perceived effi-
cacy to request mammography from her physician if the
doctors forget to order it or neglect it. The item “I can
request from my physician to prescribe getting mammo-
gram” was added.
According to experts’ recommendation to measure the
extent to which one’s self-efficacy is unaffected by others’
support, the following question was added: “Even if no-
body comes to me, I can go by myself to mammography
center.” There was an agreement between experts that
barriers to mammography for Iranian women include
mammography being painful, feelings of shame associated
with taking clothes off during mammography, old age,
and having a family history of breast cancer. Therefore,
the items “Even if I know that mammography is a little
painful, I can do it”,” I can take clothes off and not be
ashamed of it”, “I can still get mammograms despite being
older”, and “Even if I have a family history of breast can-
cer, I can get a mammogram” were added to the scale.
The CVI for the MSS was 94.8 which indicated that the
scale was suitable for use in this population.
Breast Cancer Fear Scale (BCFS)
This instrument was based on the CBCFS which is a
self-report scale that includes 8 items [13]. The items
included in this scale were also reviewed by the expert
panel. Because there are several overlapping meanings
for the term “upset” in the in Farsi language, a psycholo-
gist on the expert panel was asked to choose the best
equivalent term for the word “upset” in one of the items.
The psychologist made the suggestion to use “unhappy”
as the most suitable Farsi equivalent or replacement for
the term “upset”. The CVI for the BCFS was 98.5 suggest-
ing an appropriate scale for use in this group of people.
Pilot study of the instruments
To determine if the women found the questions clear
and easy to understand, a pilot study was conducted
using a convenience sample of 37 Iranian women who
referred to healthcare centers. The inclusion criteria for
pilot study included women who aged 40 or older, did
not have breast cancer, and did not breastfeed or being
pregnant, having had at least 1 mammogram in the past
two years, and having the ability to read and write Farsi.
There were no comments regarding the questionnaire
and participants revealing that the questions were very
clear. For the main sample size, the aforementioned
inclusion criteria were also considered.
Sample size, and sampling method
Participants were selected from women referring to
healthcare centers in Sanandaj, Iran. Since there
should be at least 10 participants per each item to
conduct an exploratory factor analysis [26], 241
women were targeted for the 8-item breast cancer fear
scale and 15-item Farsi mammography self-efficacy
scale. In accordance with a cluster random sampling
method, 6 centers were randomly selected from 23
centers. From each of the centers, 44 women were
randomly selected for the study. The same procedure
was replicated to recruit participants for conducting a
confirmatory factor analysis (CFA). Finally, a consent
form about the aim of the study was given to 525
women, and 507 agreed to participate (95%). The data
from 18 of these participants were not used due to
missing data. The Ethical Committee of Kurdistan
University of Medical Sciences approved the study.
The ethics code of this study is MUK.REC.1392.63.
Statistical Analysis
Data were analyzed using SPSS, version 20 and STATA
13 software. Independent t tests were performed to test
relationships between demographic variables, self-
efficacy, and fear, and x2 tests were used to examine
relationships between demographic variables and mam-
mography adherence. The reliability coefficient for each
scale was calculated using: (a) Cronbach’s alpha, (b)
corrected item-total correlations with a criteria of at
least 0.30, and (c) a value below 0.10 for the change in
Cronbach’s alpha when an item was dropped from the
scale [26]. The stability of the scales was tested using
test-retest reliability over a 2-week interval. The Kaiser-
Meyer-Olkin (KMO) measure of sampling adequacy
was also applied. Principal component analysis with
Varimax rotation was used to extract factors using a
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loading criteria of 0.4 or above. The technique of esti-
mation was Robust Maximum Likelihood. Fit indices in
CFA was used to examine the fit of the model, includ-
ing ratio of (X2/df < 3), the Comparative Fit Index
(CFI > 0.90), Tucker Lewis Index (TLI > 0.95), Root
Mean Square Error of Approximation (RMSEA), and
Standardized Root Mean Square Residual (SRMSR)
where the values ranged from zero to one.
Results
Demographic Characteristics
The Participants’ age ranged from 40 to 70 years and
the mean age was 47.35 (SD = 9.81 years). Most of the
women were married (88%) and homemakers (61%)
and half of them had a high school diploma or univer-
sity degree (51%). With regard to health insurance,
89.6% were insured. About a third of the sample
(N = 155) reported having had at least one mammo-
gram in the previous 2 years. Family history of breast
cancer in a first–degree relative was reported by 3% of
the participants and 12% reported having a history of
breast problems such as pain, nipple discharge, and/or
a lump (Table 1).
Mammography adherence was classified as a binary
variable, with 0 representing having one mammogram in
previous 2 years and 2 representing having two or more
mammograms in previous 2 years. The x2 test results
showed health insurance (x2 = 9.28, df = 3, p < .02),
menopause status (x2 = 8.41, df = 1, p < .006), family
history of breast cancer (x2 = 5.02, df = 1, p < .02), and a
history of personal breast problem (x2 = 33.19, df = 1,
p < .001) were associated with mammography behavior.
There was a significant difference in self-efficacy
between women who had and had not had two or
more mammograms (t = 5.19, p < .001) with women
who had had a mammogram reporting higher self-
efficacy scores. There was no significant difference on
the fear scale in accord with mammography utilization
(t = 1.75, p = .080).
Reliability
Internal consistency and item-total correlation analysis
Reliability of the scales was acceptable, as assessed using
the Cronbach’s alpha coefficient. The total scale coefficients
were 0.87 for MSS and 0.95 for BCFS (Tables 2 and 4).
Stability
The temporal stability of the scales was assessed using
test-retest reliability over a 2-week interval with a ran-
dom sub-sample of 43 women. The correlation coeffi-
cients for MSS and BCFS were 0.96 and 0.85,
respectively (p < 0.001).
Construct Validity
Exploratory factor analysis, Farsi version of mammography
self-efficacy scale
Before extracting factors, KMO measure of sampling
adequacy and Bartlett test of sphericity were conducted
to ensure that the data were suitable for factor analysis.
The KMO test gave the value of 0.87 and the BTS test
the value of 1247.87 (df = 66, P < 0.001), suggesting the
suitability of the data for analysis. The principal compo-
nent exploratory factor analysis showed that the 14-item
















No child 26 (5.4)
1-3 346 (71.8)







History of personal breast problem
Yes 58 (12.0)
No 424 (88.0)




Yes 432 ( 89.6)
No 50 (10.4)
History of having mammography in past 2 y
Yes 155 (32.4)
No 327 (67.6)
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self-efficacy for mammography scale showed a 2-factor
solution with eigenvalues greater than 1, which together
accounted for 56% of the variance. Item-total correlation
values ranged from 0.39 to 0.74, which justified combin-
ing the 2 factors into 1 self-efficacy scale [27]. The item,
“I can talk to people at the mammogram center about
my concerns,” did not meet the factor loading criterion
and hence, it was eliminated. Table 2 summarizes the
range of factor loadings for the items retained for each
factor as well as the eigenvalues and variance explained
for each factor.
Confirmatory factor analysis, Farsi version of the
mammography self-efficacy scale
The results of confirmatory factor analysis with 14
items revealed a poor fitting model according to fit in-
dices: X 2 = 477, CFI =0.76, TLI =0.71, RMSEA = 0.14
and SRMSR =0.24. An examination of the modification
indices suggested the addition of correlated errors on
item 3 pairs of items on factor 1 and 4 pairs of items
on factor 2. The investigators decided to allow these
correlations between errors based on the conceptual
meaning of the items (SE 2), (SE 7), and (SE 3) reflect-
ing logistics (e.g., transport, making appointment, and
arranging procedures). The items (SE 8) and (SE 9)
reflect the dimension of logistical steps related to the
process of getting a mammogram; knowing how to
obtain a mammogram, and finding the mammogram
facility. In the modified model, error correlations were
also set between items (SE 12) and (SE 13) related to
performance magnitude (shame and aging). The modi-
fication index suggested a correlated error term be-
tween items (SE 5) and (SE 14) which both were related
to being unaware of what to expect. In the modified
model, the × 2 value decreased compared to the value
in the initial model (x2 /df = 2.4 that was less than 3
indicating good fit, × 2 = 168, CFI = 0.93, TLI = 0.96,
RMSEA =0.05 and SRMSR =0.07 (Table 3; Fig. 1).
Table 2 Factor loadings, item analysis, and the item total correlations for the 14 items in the Farsi version of the mammography
self-efficacy scale (N=230)








1. I can ask doctor to prescribe a mammography 0.262 0.455 4.00 (.665) 0.41 .87
2. I can arrange transportation to get a mammogram 0.070 0.734 3.78 (.831) 0.39 .87
3. I can arrange other things in my life to have a mammogram 0.445 0.584 3.94 (.656) 0.58 .87
4. I can get a mammogram even if I am worried 0.598 0.457 4.01 (.629) 0.53 .94
5. I can get a mammogram even if I do not know what to expect 0.493 0.523 4.02 (.651) 0.63 .86
6. I can find a way to pay for a mammogram 0.081 0.751 3.91 (.804) 0.51 .87
7. I can make an appointment for a mammogram 0.434 0.708 4.04 (.621) 0.74 .85
8. I know how to go about getting a mammogram 0.404 0.537 3.84 (.801) 0.56 .86
9. I can find a place to have a mammogram 0.454 0.568 4.05 (.691) 0.64 .86
10. Even if nobody comes to me, I myself can go to mammography
center
0.314 0.598 3.88 (.881) 0.56 .86
11. Although I know that mammography is a little painful, I can do it 0.830 0.209 4.01 (.642) 0.65 .86
12. I can take clothes off and not ashamed of it when mammogram 0.746 0.082 3.89 (.778) 0.49 .87
13. I can still get mammograms despite of high aging 0.796 0.233 3.99 (.716) 0.63 .86
14. Even if I have a family history of breast cancer, I can get
mammography
0.798 0.250 4.10 (.614) 0.66 .86
Eigenvalue 5.33 1.37
Variance (%) 44.48 11.48
Total variance (%) 55.96
Cronbach α .87
Scale mean (SD) 47.60 (5.69)
*Bolded indicates highest factor loadings
Table 3 The fit indexes of the initial and revised model of the
confirmatory factor analyses for Farsi version of the
mammography self-efficacy scale (N=252)
Indexes Values
x 2 df x 2/df CFI TLI RMSEA SRMSR
Initial mode 447 77 5.8 0.76 0.71 0.14 0.24
Revised model 168 69 2.4 0.93 0.96 0.07 0.05
Abbreviations: CFI Comparative Fit Index, RMSEA Root Mean Square Error of
Approximation, SRMSR Standardized Root Mean Square Residual, TLI Tucker
Lewis Index
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Exploratory factor analysis, Farsi version of breast cancer
fear scale
The KMO test result showed the value of 0.88 and
the BTS test the value of 2039.45 (df = 28, p < 0.001)
suggesting the suitability of the data for analysis.
Exploratory factor analysis with principal components
showed a single factor solution for the 8-item breast
cancer fear scale, which explained 74% of the variance
with factor loading values in the range of 0.64 to 0.80
representing a strong relationship between each item
and the corresponding factor (Table 4).
Confirmatory factor analysis, Farsi version of the breast
cancer fear scale
The confirmatory factor analysis model for the cancer fear
scale can be seen in Table 5 and was as follows: × 2 = 420,
Fig. 1 Standardized solution for the revised model based on confirmatory factor analysis for mammography self-efficacy. Numbers in circles in
rectangles indicate measurement errors. Note: the SE 4 not entered into confirmatory factor analysis because of not meeting the
factor-loading criterion
Table 4 Factor loadings, item analysis, and the item total correlations for the 8 items in the Farsi version of the breast cancer fear
scale (N=230)
Fear Factor loading Item Mean (SD) Corrected Item/Total Correlation α if Item Deleted
1. When I think about breast cancer, I get scared. 0.703 3.56 (1.15) 0.64 .95
2. When I think about breast cancer, I feel nervous. 0.776 3.45 (1.12) 0.73 .93
3. When I think about breast cancer, I get unhappy. 0.759 3.56 (1.07) 0.71 .94
4. When I think about breast cancer, I get depressed. 0.669 3.10 (1.19) 0.53 .94
5. When I think about breast cancer, I get Edgy. 0.641 2.97 (1.16) 0.69 .93
6. When I think about breast cancer, my heart beats faster. 0.764 3.03 (1.18) 0.71 .96
7. When I think about breast cancer, I feel uneasy. 0.784 3.32 (1.17) 0.74 .94




Scale mean (SD) 26.29 (7.95)
*Bolded indicates highest factor loadings
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CFI =0.80, TLI =0.72, RMSEA = 0.28 and SRMSR =0.06.
The fit indices suggested a lack of fit with the data. In
order to improve model fit, a correlated error term was
added between items 7 and 8, which both related to intru-
sive thoughts. The final model provided a good fit to the
data: × 2 = 86.33, CFI =0.99, TLI =0.99, RMSEA =0.04 and
SRMSR =0.01 (Table 5; Fig. 2).
Discussion
This study provided a cross-cultural adaptation and
validation of mammography self-efficacy and breast can-
cer fear scales in Farsi for Iranian women. Processes of
translation, back translation, and cultural adaptation of
the questionnaires were conducted by experts. The
results of this study provided initial evidence for the reli-
ability and validity of both scales. This was a significant
work resulting in considerable revisions to the original in-
struments, in particular to the mammography self-efficacy
scale. This may be in part due to the influences of both
culture and religion that result in non-applicability of these
across different populations seamlessly [20]. While the psy-
chometric properties of the mammography self-efficacy
scale were previously evaluated by Hashemian in Sabzevar
[20], the current work was conducted in Sanandaj that is a
city in the western Iran with a distinct culture and religion
from Sabzevar. As expected, the culture and religion in
Sanandaj led to different results regarding mammography
self-efficacy in comparison with previous study [20]. Our
results were different on the 6 items relating to mammog-
raphy self-efficacy. For example, the item “I can ask doctor
to prescribe a mammography”. Bandura [11] identified
verbal persuasion and social influence that would wary by
cultures and can influence one’s self-efficacy as one of four
sources that build self-efficacy [28]. A persuasive caregiver
may be able to influence a woman’s decisions. Women in
current sample might be more inclined to mammography
by doctor’s recommendation. In addition, the items “I can
take clothes off and not ashamed of it when [having a]
mammogram” and “I can get mammograms despite of
high aging [getting older]” that are influenced by cul-
ture and religion effects as other researchers have
shown [29–31]. Investigating the other item “Even if I
have a family history of breast cancer, I can get mam-
mography [a mammogram]” and “although mammog-
raphy is a little painful, I can do it” showed that having
a family history of breast cancer, fear of finding a lump,
or mammograms being painful cannot prevent women
from getting a mammogram. This item related to
physiological and affective states is a fourth source in-
fluences one’s self-efficacy which is in line with Bandura
[28]. Bandura describes self-efficacy as having several
dimensions. For example, self-efficacy beliefs may vary
in strength. People may have strong or weak beliefs
about their ability to perform specific steps related to a
recommend behavior [28]. The item “Even if nobody
comes to me, I can go to the mammography center” re-
flects a dimension of self-efficacy. The participants of
current study perceived strength as the degree of certainty
they have regarding their ability to get a mammogram.
Finally, our results did not meet the factor loading criter-
ion for the two items “talk to people at the mammogram
center about my concern” and “sure can get a mammo-
gram if I really want to” in Hashemian’s study.
Table 5 The fit indexes of the initial and revised model of the
confirmatory factor analyses for the Farsi version of the breast
cancer fear scale (N=252)
Indexes Values
x 2 df x 2/df CFI TLI RMSEA SRMSR
Initial model 420 20 21 0.80 0.72 0.28 0.06
Revised model 86.33 15 5.7 0.99 0.99 0.04 0.01
Abbreviations: CFI Comparative Fit Index, RMSEA Root Mean Square Error of
Approximation, SRMSR Standardized Root Mean Square Residual, TLI Tucker
Lewis Index
Fig. 2 Standardized solution for the revised model based on confirmatory factor analysis of fear of breast cancer scale. Numbers in circles in
rectangles indicate measurement errors
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MSS items loaded on factor 1 measured physiological
states like having feelings of worry, pain, shame, being
too old, and fear resulting from a breast cancer family
history. Those items loaded on factor 2 measured one’s
self-efficacy in the process of getting a mammogram.
These results are in contrast with the finding Champion
[18], Secginli [19], and Hashemian [20] in which all
items loaded on a single factor. This contradictory result
might be related to the additional items that our expert
panel added to the instrument. Another explanation
may be linked to cultural differences across study popu-
lations. The barriers that were added in the current
study might not be considered as relevant for women
that live in Sanandaj, but are for women in Turkey [19],
the USA [12], and Sabzevar [20]. The panel of experts
considered that all self-efficacy aspects should be dealt
with in this screening behavior to the extent possible
when considering the items. Bandura [10] suggested that
measures of perceived self-efficacy should be tailored to
the particular domain of functioning which is the object
of interest. Furthermore, self-efficacy assessments must
reflect the level of difficulty individuals believe they can
overcome.
The adapted Farsi version of the self-efficacy for mam-
mography scale consisted of 14 items. Most of the stan-
dardized factor loadings were moderate to large, suggesting
that the majority of the observed variables were good mea-
sures of their latent construct. The standardized factor
loadings ranged from 0.45 to 0.83 for the MSS items. These
results are comparable with those reported in Champion’s
study where factor loadings were within 0.37–0.76 [12].
The results of Secginli’s study showed a range from 0.62 to
0.82 and of Hashemian’s from 0.54 to 0.94 for the corre-
sponding self-efficacy items [19, 20].
The Farsi version of the MSS had an internal consistency
reliability comparable to previous versions. The Cronbach’s
alpha coefficient for the MSS was 0.87, which is acceptable.
In Champion’s and Secginli’s studies, in which the MSS
included 10 items, the Cronbach’s alpha values were 0.94
[12, 18], and 0.90, respectively. Hashemian et al., reported
Cronbach’s alpha of 0.90 for the MSS [20].
The Farsi version of the breast cancer fear scale in
this study brought about results similar to the ones
reported in the original English version by Champion
in which all items loaded onto one factor [13], but
they were not in agreement with the findings of
Secginli in Turkey [19], where the items loaded onto
2 factors. In the current study, the standardized factor
loadings ranged from 0.64 to 0.80. The breast cancer
fear item loadings in our study were somewhat lower
than those found in Champion’s study where factor
loadings were within 0.75–0.86 [13], and in Secginli’s
study were within 0.71 to 0.85 for the corresponding
breast cancer fear items [19]. The Cronbach’s alpha
coefficient for BCFS was 0.95. This result is compar-
able with those obtained by Champion and Secginli
who reported Cronbach’s alpha coefficients as 0.94
and 0.90 [13, 19], respectively.
Conclusion
This study provided a cross-cultural adaptation and val-
idation of mammography self-efficacy and breast cancer
fear scales in Farsi context. It is the first study where
investigators tested the psychometric properties of a
translated Farsi version of breast cancer fear among
Iranian women. Mammography behavior should done in
long intervals (once a year for women 50 or older), in
contrast with lifestyle behaviors like exercise that should
be done daily. Therefore, comprehensive psychometric
work will help providing measures of perceived mam-
mography self-efficacy that capture the distinct compo-
nents of this concept. Future research are recommended
to examine if MSS version can measure three dimen-
sions of self-efficacy: generality, magnitude, and strength
related to mammography behavior. Future research can
test these instruments among women participating in
mammography screening in a variety of health service
settings or among women with different cultural back-
grounds to increase the generalizability of the results.
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